Eledon Pharmaceuticals (ELDN) Net Cash Flow (2016 - 2017)
Historic Net Cash Flow for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$3.4 million.
- Eledon Pharmaceuticals' Net Cash Flow fell 34199.72% to -$3.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was $16.8 million, marking a year-over-year increase of 27002.43%. This contributed to the annual value of $15.9 million for FY2024, which is 13076.82% up from last year.
- According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Net Cash Flow is -$3.4 million, which was down 34199.72% from $17.6 million recorded in Q2 2017.
- Over the past 5 years, Eledon Pharmaceuticals' Net Cash Flow peaked at $84.3 million during Q3 2014, and registered a low of -$35.1 million during Q2 2015.
- For the 5-year period, Eledon Pharmaceuticals' Net Cash Flow averaged around $1.1 million, with its median value being -$2.3 million (2016).
- Per our database at Business Quant, Eledon Pharmaceuticals' Net Cash Flow tumbled by 429663.46% in 2015 and then surged by 13953.7% in 2017.
- Eledon Pharmaceuticals' Net Cash Flow (Quarter) stood at $8.6 million in 2013, then plummeted by 102.41% to -$208000.0 in 2014, then plummeted by 4296.63% to -$9.1 million in 2015, then skyrocketed by 86.12% to -$1.3 million in 2016, then crashed by 169.27% to -$3.4 million in 2017.
- Its Net Cash Flow stands at -$3.4 million for Q3 2017, versus $17.6 million for Q2 2017 and $3.8 million for Q1 2017.